West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China.
Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu, China.
Front Endocrinol (Lausanne). 2023 Jan 4;13:1098325. doi: 10.3389/fendo.2022.1098325. eCollection 2022.
The present systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to investigate the effect of low volume high-intensity interval training (LVHIIT) on the metabolic and cardiorespiratory outcomes in patients with type 2 diabetes mellitus (T2DM).
Relevant articles were sourced from PubMed, EBSCO, Web of Science, Embase, and the Cochrane Library from inception to October 2022. The study search strategy and all other processes were implemented in accordance with the PRISMA statement.
Five randomized controlled trials that satisfied the inclusion criteria were included in this meta-analysis. The LVHIIT group had significantly lower fasting blood glucose levels (RR= -1.21; 95% CI= -2.02- -0.40, p = 0.0032) and HbA1c levels (RR= -0.65; 95% CI= -1.06- -0.23, p = 0.002) and higher levels of insulin resistance indicator HOMA-IR (RR= -1.34; 95% CI = -2.59- -0.10, p = 0.03) than the control group. Moreover, our results show that LVHIIT can reduce body mass (RR = -0.94, 95% CI = -1.37- -0.51, p<0.0001) and body mass index (RR = -0.31, 95% CI = -0.47- -0.16, p<0.0001). LVHIIT had a better therapeutic effect on blood lipid metabolism, such as total cholesterol, high-density lipoprotein, low-density lipoprotein and triglycerides. However, the change in fasting insulin levels was not statistically significant (RR= -1.43; 95% CI = -3.46- 0.60, p =0.17). Furthermore, LVHIIT reduced the systolic blood pressure (RR =-4.01, 95% CI = -4.82 - -3.21, p<0.0001) and improved peak oxygen uptake (VO) compared to the control group (RR= 5.45; 95% CI = 1.38 - 9.52, p =0.009).
After a certain period of LVHIIT, glycaemic control, insulin resistance, body weight, lipid profile and cardiorespiratory outcomes were significantly improved in T2DM patients.
本系统评价和荟萃分析旨在调查低容量高强度间歇训练(LVHIIT)对 2 型糖尿病(T2DM)患者代谢和心肺结局的影响。
从 PubMed、EBSCO、Web of Science、Embase 和 Cochrane Library 中检索到了从成立到 2022 年 10 月的相关文章。研究检索策略和所有其他过程均按照 PRISMA 声明进行。
本荟萃分析纳入了 5 项符合纳入标准的随机对照试验。LVHIIT 组的空腹血糖水平(RR=-1.21;95%CI=-2.02 至-0.40,p=0.0032)和 HbA1c 水平(RR=-0.65;95%CI=-1.06 至-0.23,p=0.002)明显降低,胰岛素抵抗标志物 HOMA-IR 水平(RR=-1.34;95%CI=-2.59 至-0.10,p=0.03)更高,而对照组则更低。此外,我们的结果表明,LVHIIT 可以降低体重(RR=-0.94,95%CI=-1.37 至-0.51,p<0.0001)和体重指数(RR=-0.31,95%CI=-0.47 至-0.16,p<0.0001)。LVHIIT 对血脂代谢(如总胆固醇、高密度脂蛋白、低密度脂蛋白和甘油三酯)有更好的治疗作用。然而,空腹胰岛素水平的变化没有统计学意义(RR=-1.43;95%CI=-3.46 至 0.60,p=0.17)。此外,与对照组相比,LVHIIT 降低了收缩压(RR=-4.01,95%CI=-4.82 至-3.21,p<0.0001)并改善了峰值摄氧量(VO)(RR=5.45;95%CI=1.38 至 9.52,p=0.009)。
经过一定时间的 LVHIIT,T2DM 患者的血糖控制、胰岛素抵抗、体重、血脂谱和心肺功能均有显著改善。